Potential Molecular Mechanism of Upregulated Aryl Hydrocarbon Receptor Nuclear Translocator 2 in Nasopharyngeal Carcinoma

BACKGROUND: Currently, the benefits of nasopharyngeal carcinoma (NPC) therapy are limited, and it is necessary to further explore possible therapeutic targets. Aryl hydrocarbon receptor nuclear translocator 2 (ARNT2) has been extensively studied in other cancer species, but little has been explored...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Si-Wei, Chen, Gang, Li, Jian-Di, Qin, Li-Ting, Huang, Zhi-Guang, Huang, Su-Ning, Lu, Wei, Zeng, Jiang-Hui, Mo, Bin-Yu, Dang, Yi-Wu, Wei, Zhu-Xin, Luo, Jia-Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9532129/
https://www.ncbi.nlm.nih.gov/pubmed/36203533
http://dx.doi.org/10.1155/2022/9137282

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9532129/
https://www.ncbi.nlm.nih.gov/pubmed/36203533
http://dx.doi.org/10.1155/2022/9137282

Ejemplares similares